On Stumble, Arianna Davis plays narcoleptic cheerleader Madonna, who often passes out while performing. Learn more about the ...
Narcolepsy type 1 is a chronic, rare neurological disease caused by the loss of orexin neurons in the brain. Orexin is a ...
Generated LUMRYZ™ net product revenue of $77.5 million, a 55% increase compared to third quarter 2024 –– Approximately 3,400 patients on LUMRYZ ...
Detailed price information for Harmony Biosciences Holdings Inc (HRMY-Q) from The Globe and Mail including charting and trades.
ORX750: Demonstrated potential best-in-class profile for treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic ...
New data shows surging public interest in sleep-related problems, with online searches for "ways to help sleeping" jumping ...
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced preliminary results for Q3 2025, highlighted by the following: WAKIX® (pitolisant) franchise delivered net revenue of approximately ...
Axsome Therapeutics, Inc. remains a Sell due to an undifferentiated CNS pipeline, heavy SG&A and net losses. Learn more about ...
Detailed price information for Avadel Pharmaceuticals Plc ADR (AVDL-Q) from The Globe and Mail including charting and trades.
Viatris Inc. (Nasdaq: VTRS) today reported strong third quarter 2025 financial results and updated full-year financial ...
Q3 2025 Earnings Call Transcript November 6, 2025 Viatris Inc. beats earnings expectations. Reported EPS is $0.67, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback